Marbofloxacin
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Marbofloxacin(F05645) |
| 2D Structure | |
| FRCD ID | F05645 |
| CAS Number | 115550-35-1 |
| PubChem CID | 60651 |
| Formula | C17H19FN4O4 |
| IUPAC Name | None |
| InChI Key | BPFYOAJNDMUVBL-UHFFFAOYSA-N |
| InChI | InChI=1S/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H,3-6,9H2,1-2H3,(H,24,25) |
| Canonical SMILES | CN1CCN(CC1)C2=C(C=C3C4=C2OCN(N4C=C(C3=O)C(=O)O)C)F |
| Isomeric SMILES | CN1CCN(CC1)C2=C(C=C3C4=C2OCN(N4C=C(C3=O)C(=O)O)C)F |
| Synonyms |
Marbofloxacine
Marbofloxacin
115550-35-1
Zeniquin
Marbocyl
Marbofloxacine [INN-French]
Marbofloxacinum [INN-Latin]
Marbofloxacino [INN-Spanish]
UNII-8X09WU898T
BPFYOAJNDMUVBL-UHFFFAOYSA-N
|
| Classifies |
Predicted: Plant Toxin
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Organoheterocyclic compounds |
| Class | Quinolines and derivatives |
| Subclass | Quinoline carboxylic acids |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Quinoline carboxylic acids |
| Alternative Parents |
|
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Quinoline-3-carboxylic acid - Fluoroquinolone - N-arylpiperazine - Aminoquinoline - Haloquinoline - Dihydroquinolone - Dihydroquinoline - Pyridine carboxylic acid - Pyridine carboxylic acid or derivatives - Tertiary aliphatic/aromatic amine - Dialkylarylamine - N-methylpiperazine - N-alkylpiperazine - 1,4-diazinane - Aryl halide - Aryl fluoride - Piperazine - Pyridine - Benzenoid - Heteroaromatic compound - Vinylogous amide - Amino acid or derivatives - Amino acid - Tertiary amine - Tertiary aliphatic amine - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Azacycle - Carboxylic acid - Oxacycle - Amine - Organopnictogen compound - Organic oxygen compound - Organic oxide - Organohalogen compound - Organofluoride - Organonitrogen compound - Organooxygen compound - Organic nitrogen compound - Hydrocarbon derivative - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 362.361 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 2 |
| Complexity | 636 |
| Monoisotopic Mass | 362.139 |
| Exact Mass | 362.139 |
| XLogP | -0.5 |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB- | 0.9038 |
| Human Intestinal Absorption | HIA+ | 0.9840 |
| Caco-2 Permeability | Caco2+ | 0.6696 |
| P-glycoprotein Substrate | Substrate | 0.7128 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7311 |
| Non-inhibitor | 0.7908 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7863 |
| Distribution | ||
| Subcellular localization | Lysosome | 0.4781 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8964 |
| CYP450 2D6 Substrate | Non-substrate | 0.8564 |
| CYP450 3A4 Substrate | Substrate | 0.5141 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6635 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9280 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8104 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7696 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7516 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8492 |
| Non-inhibitor | 0.7841 | |
| AMES Toxicity | AMES toxic | 0.9107 |
| Carcinogens | Non-carcinogens | 0.8054 |
| Fish Toxicity | High FHMT | 0.9976 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9408 |
| Honey Bee Toxicity | Low HBT | 0.8944 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.7245 |
| Carcinogenicity (Three-class) | Non-required | 0.6124 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -3.5251 | LogS |
| Caco-2 Permeability | 1.1188 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.4016 | LD50, mol/kg |
| Fish Toxicity | 1.1461 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.6464 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Milk | Japan | 0.08ppm | |||
| Pig,Edible Offal | Japan | 0.2ppm | |||
| Cattle,Edible Offal | Japan | 0.2ppm | |||
| Pig,Kidney | Japan | 0.2ppm | |||
| Cattle,Kidney | Japan | 0.2ppm | |||
| Pig,Liver | Japan | 0.2ppm | |||
| Cattle,Liver | Japan | 0.2ppm | |||
| Pig,Fat | Japan | 0.05ppm | |||
| Cattle,Fat | Japan | 0.05ppm | |||
| Pig,Muscle | Japan | 0.2ppm | |||
| Cattle,Muscle | Japan | 0.2ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Prevalence of most common human pathogenic Campylobacter spp. in dogs and cats inStyria, Austria. | Vet Med Sci | 2018 May | 29851311 |
| Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia afterexperimental aerosol inoculation of nursery pigs. | Porcine Health Manag | 2018 Jun 22 | 29977591 |
| Pharmacokinetics of marbofloxacin administered via intravenous regional limbperfusion in dairy cows: evaluation of two different tourniquets. | Vet Rec Open | 2017 Sep 26 | 29018533 |
| Tissue distribution of marbofloxacin in pigs after a single intramuscularinjection. | J Vet Sci | 2017 Jun 30 | 27515270 |
| Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulationof marbofloxacin, after intravenous and intramuscular administration to lactatinggoats. | J Vet Pharmacol Ther | 2017 Dec | 28470723 |
| Efficient Reduction of Antibacterial Activity and Cytotoxicity of Fluoroquinolones by Fungal-Mediated N-Oxidation. | J Agric Food Chem | 2017 Apr 19 | 28365994 |
| Determination of marbofloxacin in plasma and synovial fluid by ultrafiltrationfollowed by HPLC-MS/MS. | J Pharm Biomed Anal | 2016 May 10 | 26859613 |
| A Liquid Chromatography-Tandem Mass Spectrometry Method for the Detection ofAntimicrobial Agents from Seven Classes in Calf Milk Replacers: Validation andApplication. | J Agric Food Chem | 2016 Mar 30 | 26971558 |
| Use of micellar liquid chromatography to analyze oxolinic acid, flumequine,marbofloxacin and enrofloxacin in honey and validation according to the2002/657/EC decision. | Food Chem | 2016 Jul 1 | 26920300 |
| Wildlife contamination with fluoroquinolones from livestock: Widespreadoccurrence of enrofloxacin and marbofloxacin in vultures. | Chemosphere | 2016 Feb | 26498102 |
| Electrical field assisted matrix solid phase dispersion as a powerful tool toimprove the extraction efficiency and clean-up of fluoroquinolones in bovinemilk. | J Chromatogr A | 2016 Aug 26 | 27492598 |
| Antibiotics and sweeteners in the aquatic environment: biodegradability,formation of phototransformation products, and in vitro toxicity. | Environ Sci Pollut Res Int | 2015 Nov | 26169816 |
| Microbial screening for quinolones residues in cow milk by bio-optical method. | J Pharm Biomed Anal | 2015 Mar 15 | 25555518 |
| Using deconvolution to understand the mechanism for variable plasmaconcentration-time profiles after intramuscular injection. | Int J Pharm | 2015 Mar 15 | 25636300 |
| Luminescent determination of quinolones in milk samples by liquidchromatography/post-column derivatization with terbium oxide nanoparticles. | J Chromatogr A | 2015 Jul 31 | 26077970 |
| Multiresidue determination of fluoroquinolones in poultry muscle and kidneyaccording to the regulation 2002/657/EC. A systematic comparison of two differentapproaches: Liquid chromatography coupled to high-resolution mass spectrometry ortandem mass spectrometry. | J Chromatogr A | 2015 Jan 30 | 25577647 |
| Determination of fluoroquinolones in chicken feces - a new liquid-liquidextraction method combined with LC-MS/MS. | Environ Toxicol Pharmacol | 2014 Nov | 25305740 |
| Comparison of different solid-phase extraction materials for the determination offluoroquinolones in chicken plasma by LC-MS/MS. | J Chromatogr B Analyt Technol Biomed Life Sci | 2014 Mar 1 | 24566266 |
| Development of a novel genetically modified bioluminescent-bacteria-based assayfor detection of fluoroquinolones in animal-derived foods. | Anal Bioanal Chem | 2014 Dec | 25354889 |
| Development of a highly sensitive and specific immunoassay for enrofloxacin basedon heterologous coating haptens. | Anal Chim Acta | 2014 Apr 11 | 24745749 |